Interpretation and thoughts on the formulation and revision of the standards for exogenous harmful residues in traditional Chinese medicinal materials in the Chinese Pharmacopoeia 2025 Edition
10.19778/j.chp.2025.01.012
- VernacularTitle:2025年版《中国药典》中药中外源性有害残留物检测标准制修订解读与思考
- Author:
WANG Ying
;
SHEN Mingrui
;
LIU Yuanxi
;
ZUO Tiantian
;
WANG Dandan
;
HE Yi
;
CHENG Xianlong
;
JIN Hongyu
;
LIU Yongli
;
WEI Feng
;
MA Shuangcheng
- Publication Type:Journal Article
- Keywords:
traditional Chinese medicine;
exogenous harmful residues;
Chinese Pharmacopoeia 2025 Edition;
development direction
- From:
Drug Standards of China
2025;26(1):083-092
- CountryChina
- Language:Chinese
-
Abstract:
As people’s attention to health continues to increase, the market demand for traditional Chinese medicine (TCM) is growing steadily. The quality and safety of Chinese medicinal materials have attracted unprecedented social attention. In particular, the issue of exogenous harmful residue pollution in TCM has become a hot topic of concern for both regulatory authorities and society. The Chinese Pharmacopoeia 2025 Edition further refines the detection methods and limit standards for exogenous harmful residues in TCM. This not only reflects China’s high-level emphasis on the quality and safety of TCM but also demonstrates the continuous progress made by China in the field of TCM safety supervision. Basis on this study, by systematically reviewing the development history of the detection standards for exogenous harmful residues in TCM and analyzing the revisions and updates of these detection standards in the Chinese Pharmacopoeia 2025 Edition, deeply explores the key points of the changes in the monitoring standards for exogenous harmful residues in TCM in the Chinese Pharmacopoeia 2025 Edition. Moreover, it interprets the future development directions of the detection of exogenous residues in TCM, aiming to provide a reference for the formulation of TCM safety supervision policies.
- Full text:202503111418365728320250212.pdf
